Care access platform DexCare closed a $75 million Series C equity funding round Wednesday.
The company said it will use the capital to increase its specialty care offerings in areas where existing provider customers have expressed demand, such as orthopedics and oncology.
The round comes as digital health funding continues to see a massive drop-off in venture capital funding and deal activity, according to a report from Pitchbook published…